NCT06781879View on ClinicalTrials.gov

Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

PHASE4RecruitingINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

February 1, 2029

Study Completion Date

February 1, 2032

Conditions
Non-Muscle Invasive Bladder Cancer
Interventions
DRUG

Mitomycin c

Chemoablation

Trial Locations (8)

8200

RECRUITING

Aarhus University Hospital, Aarhus N

Unknown

NOT_YET_RECRUITING

Aalborg University Hospital, Aalborg

RECRUITING

Herlev and Gentofte Hospital, Herlev

RECRUITING

Zealand University Hospital, Roskilde, Roskilde

NOT_YET_RECRUITING

Landspítali University Hospital, Reykjavik

NOT_YET_RECRUITING

Haukeland University Hospital, Bergen

NOT_YET_RECRUITING

Vestfold Hospital Trust, Tønsberg

NOT_YET_RECRUITING

NU Hospital Group, Uddevalla

All Listed Sponsors
collaborator

medac GmbH

INDUSTRY

collaborator

Danish Cancer Society

OTHER

lead

Jakob Kristian Jakobsen

OTHER